An Investigation of the Cervical Region Biomechanics in Patients With Chronic Obstructive Pulmonary Disease
Launched by HACETTEPE UNIVERSITY · Jan 30, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how the neck and upper back work in people with Chronic Obstructive Pulmonary Disease (COPD). The researchers want to understand how muscle performance and the strength of breathing muscles differ between patients with COPD and healthy individuals. This study aims to help improve the understanding of COPD and how it can affect the body beyond just the lungs.
To participate in this trial, individuals must be diagnosed with COPD (stages 1 to 4) and be over 40 years old. They should be in stable health and able to understand the study questions. However, people with certain conditions, such as recent hospitalizations for COPD flare-ups, specific joint diseases, or recent surgeries involving the neck or spine, will not be able to join. Participants can expect to undergo assessments that will measure their muscle strength and function related to breathing and neck movement. This research is important as it may lead to better treatments and support for those living with COPD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Being diagnosed with stage 1-2-3-4 according to the Classification of Airflow Limitation in COPD (GOLD) system,
- • Being \>40 years old,
- • Being cognitively competent to understand and answer evaluation questions.
- • Being clinically stable for the last 4 weeks,
- • Being under control of accompanying comorbid conditions (such as hypertension, diabetes),
- • Volunteering to participate in the research.
- Exclusion Criteria:
- • • Having been hospitalized due to exacerbation in the last 3 months,
- • Having a musculoskeletal, neurological, rheumatological or oncological disease that affects the craniocervical \& cervicothoracic joints and/or may prevent evaluation,
- • Having undergone any surgical intervention on the craniocervicofacial region and spine in the last six months,
- • Having lung malignancy, neoplasm, adenocarcinoma,
- • Being a lung cancer patient or having received cancer treatment (head and neck lung radiotherapy), having undergone pneumonectemia, lobectomy or resection surgery,
- • Being treated for anxiety and depression,
- • Having scoliosis,
- • Having a congenital anomaly of the craniocervicofacial region.
- • Having 3 out of 4 findings according to the diagnostic criteria for cervical radiculopathy,
- • Having thoracic outlet syndrome (TOS)
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Aynur Demirel
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported